IN 1963, A PRESTIGIOUS cancer researcher in New York, NY, injected live cancer cells underneath the skin of unsuspecting, elderly, debilitated patients to study the immunological effects of this nontherapeutic exploration. No attempt was made to inform the patients or to obtain their permission.1 Following the uproar precipitated by this outrageous incident, James Shannon, Director of the National Institutes of Health (NIH), appointed an internal committee to review the issues involved in this disturbing episode. "In the setting in which the patient is involved in an experimental effort," the committee concluded, "the judgment of the investigator is not sufficient as a basis for reaching a conclusion concerning the ethical and moral set of questions in that relationship."
Silverman WA. Bad Science and the Role of Institutional Review Boards. Arch Pediatr Adolesc Med. 2000;154(12):1183–1184. doi:10.1001/archpedi.154.12.1183
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.